Compare AAP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAP | SRPT |
|---|---|---|
| Founded | 1929 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2002 | 2000 |
| Metric | AAP | SRPT |
|---|---|---|
| Price | $52.13 | $16.16 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 28 |
| Target Price | ★ $53.50 | $25.48 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 05-14-2026 | 06-01-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | ★ 113.01 | N/A |
| EPS | ★ 0.73 | N/A |
| Revenue | ★ $8,601,000,000.00 | $2,198,237,000.00 |
| Revenue This Year | $0.55 | N/A |
| Revenue Next Year | $2.46 | N/A |
| P/E Ratio | $71.41 | ★ N/A |
| Revenue Growth | N/A | ★ 15.58 |
| 52 Week Low | $28.89 | $10.42 |
| 52 Week High | $70.00 | $107.23 |
| Indicator | AAP | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 33.87 |
| Support Level | $50.98 | $15.51 |
| Resistance Level | $53.13 | $19.55 |
| Average True Range (ATR) | 3.16 | 0.78 |
| MACD | -0.82 | -0.16 |
| Stochastic Oscillator | 15.04 | 10.99 |
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.